Search research articles
Contact Us
Filters
Showing results (521-530 of 580) with videos related to
Page
of 58
Sort By:
International Journal of Molecular Sciences
|
April 23, 2022
Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma
Julia C Thierauf, Alex A Farahani, B Iciar Indave, et al.
Journal of the National Cancer Institute
|
September 28, 2017
Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype
Theodore S Hong, Jennifer Y Wo, Darrell R Borger, et al.
Molecular Cell
|
July 29, 2008
Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification
Morgan L Maeder, Stacey Thibodeau-Beganny, Anna Osiak, et al.
The Journal of Molecular Diagnostics : JMD
|
February 12, 2017
Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial
Chih-Jian Lih, Robin D Harrington, David J Sims, et al.
Cancer Cell
|
December 19, 2015
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
Kensuke Tateishi, Hiroaki Wakimoto, A John Iafrate, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2021
Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer
Giulia Siravegna, Connor J O'Boyle, Shohreh Varmeh, et al.
Cell
|
April 30, 2019
Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish
Chuan Yan, Dalton C Brunson, Qin Tang, et al.
JAMA
|
May 22, 2014
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs
Mark G Kris, Bruce E Johnson, Lynne D Berry, et al.
Cancer Discovery
|
September 28, 2018
Landscape of Acquired Resistance to Osimertinib in <i>EGFR</i>-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired <i>RET</i> Fusion
Zofia Piotrowska, Hideko Isozaki, Jochen K Lennerz, et al.
JCO Precision Oncology
|
October 30, 2018
Clinical Utility of Rapid <i>EGFR</i> Genotyping in Advanced Lung Cancer
Ibiayi Dagogo-Jack, Christopher G Azzolli, Florian Fintelmann, et al.
Page
of 58
Search research articles
Search
Showing results (521-530 of 580) with videos related to
Sort By:
Page
of 58
International Journal of Molecular Sciences
|
April 23, 2022
Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma
Julia C Thierauf, Alex A Farahani, B Iciar Indave, et al.
Journal of the National Cancer Institute
|
September 28, 2017
Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype
Theodore S Hong, Jennifer Y Wo, Darrell R Borger, et al.
Molecular Cell
|
July 29, 2008
Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification
Morgan L Maeder, Stacey Thibodeau-Beganny, Anna Osiak, et al.
The Journal of Molecular Diagnostics : JMD
|
February 12, 2017
Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial
Chih-Jian Lih, Robin D Harrington, David J Sims, et al.
Cancer Cell
|
December 19, 2015
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
Kensuke Tateishi, Hiroaki Wakimoto, A John Iafrate, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2021
Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer
Giulia Siravegna, Connor J O'Boyle, Shohreh Varmeh, et al.
Cell
|
April 30, 2019
Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish
Chuan Yan, Dalton C Brunson, Qin Tang, et al.
JAMA
|
May 22, 2014
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs
Mark G Kris, Bruce E Johnson, Lynne D Berry, et al.
Cancer Discovery
|
September 28, 2018
Landscape of Acquired Resistance to Osimertinib in <i>EGFR</i>-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired <i>RET</i> Fusion
Zofia Piotrowska, Hideko Isozaki, Jochen K Lennerz, et al.
JCO Precision Oncology
|
October 30, 2018
Clinical Utility of Rapid <i>EGFR</i> Genotyping in Advanced Lung Cancer
Ibiayi Dagogo-Jack, Christopher G Azzolli, Florian Fintelmann, et al.
Page
of 58